Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-02

Clinical Trial Update: Albumin and Crystalloid Administration in Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating albumin versus crystalloid fluid administration in septic shock; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin
  • Crystalloid solution (crystalloid IV fluids (e.g., normal saline or balanced crystalloids))

Snippet

Sponsor: Asan Medical Center | Conditions: Septic Shock | Phase 4 | Status: RECRUITING